News & insights

We are happy to welcome a new Analyst in our investment team: Flore Belmans. Flore will focus on identifying and analysing investment opportunities and supporting her colleagues with due diligence, deal structuring, and networking across the start-up ecosystem. With a strong scientific foundation, hands-on experience, and an early taste of venture capital, Flore brings the exact blend of scientific depth and entrepreneurial instinct that HERAN is looking for. 

Hypervision Surgical, a pioneer in real-time hyperspectral imaging for surgery, today announced the successful closing of its oversubscribed £17 million Series A financing round.

Second investment for HERAN HealthTech Fund II: Fluidic Sciences (UK)

First investment for HERAN HealthTech Fund II: Pharmacelera

2025 has been a remarkable year for HERAN. Together with our partners, teams and portfolio companies, we have taken meaningful steps forward in shaping the future of healthcare.

On October 9th, 2025, we welcomed over 100 investors, founders and stakeholders to our annual Investor Day at De Koolputten in Waasmunster. The event reflected our investment philosophy: HERAN fuels bold innovators whose technologies are transforming healthcare and life sciences.

We are proud to announce the successful exit of icometrix, an AI leader in brain imaging now acquired by GE Healthcare. What began as early conviction in a promising idea grew into a global solution for neurology care. This journey reflects our approach: building long-term partnerships rooted in trust, strategic guidance and a commitment to impact.

GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions

Aspect Analytics, a leading provider of software for spatial biology data analysis, today announced the successful closing of an oversubscribed € 10 million Series A funding round.